Ads
related to: uncontrolled hyperglycemia complications- T1D Risk Factors
Take the Type 1 Risk Quiz to
Understand Your Risk for T1D
- What You Need to Know
Learn the Risk Factors of T1D.
Take the Type 1 Risk Quiz
- Screen Early for T1D
Learn the Importance of
Screening Early
- Doctor Discussion Guide
Download the Doctor Discussion
Guide for More on Screening & T1D.
- Resources
Find Resources You Need
To Get Screened for T1D Today
- Plan For Your Future
Talk To A Doctor About T1D Symptoms
You or Your Loved One May Have
- T1D Risk Factors
Search results
Results From The WOW.Com Content Network
The issue was finally settled in 1993 with the publication of the Diabetes Control and Complications Trial. [51] In the DCCT, subjects without prior retinopathy who maintained good glycaemic control for a mean of 6.5 years were 76% less likely to develop diabetic retinopathy than subjects with less strict control.
Acute hyperglycemia involving glucose levels that are extremely high is a medical emergency and can rapidly produce serious complications (such as fluid loss through osmotic diuresis). It is most often seen in persons who have uncontrolled insulin-dependent diabetes .
Glycemic control is a medical term referring to the typical levels of BG in a person with diabetes mellitus. Much evidence suggests that many of the long-term complications of diabetes, result from many years of hyperglycemia (elevated levels of glucose in the blood). [11]
Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United States are currently living with diabetes. That’s 11.6 percent of the ...
Diabetic ketoacidosis may be diagnosed when the combination of hyperglycemia (high blood sugars), ketones in the blood or on urinalysis and acidosis are demonstrated. [6] In about 10% of cases the blood sugar is not significantly elevated ("euglycemic diabetic ketoacidosis"). [3] A pH measurement is performed to detect acidosis.
The main risk factor for diabetic neuropathy is hyperglycemia. In the DCCT (Diabetes Control and Complications Trial, 1995) study, the annual incidence of neuropathy was 2% per year but dropped to 0.56% with intensive treatment of Type 1 diabetics.